These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1816768

  • 1. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].
    Twentyman PR, Bleehen NM.
    Eur J Cancer; 1991; 27(12):1639-42. PubMed ID: 1816768
    [Abstract] [Full Text] [Related]

  • 2. Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype.
    te Boekhorst PA, van Kapel J, Schoester M, Sonneveld P.
    Cancer Chemother Pharmacol; 1992; 30(3):238-42. PubMed ID: 1352739
    [Abstract] [Full Text] [Related]

  • 3. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC, Scolnik M, Alvarez E, Hajos SE.
    Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
    [Abstract] [Full Text] [Related]

  • 4. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT, de Vries EG, Timmer-Bosscha H, Meersma GJ, Mesander G, Vellenga E, Mulder NH.
    Cancer Res; 1994 Oct 15; 54(20):5368-73. PubMed ID: 7923167
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Nissen NI.
    Cancer Chemother Pharmacol; 1992 Oct 15; 30(3):235-7. PubMed ID: 1628375
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
    Uchiyama-Kokubu N, Watanabe T, Cohen D.
    Jpn J Cancer Res; 2001 Oct 15; 92(10):1116-26. PubMed ID: 11676863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B, Nilsson K, Nygren P, Larsson R.
    Anticancer Drugs; 1992 Dec 15; 3(6):641-6. PubMed ID: 1363199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR, Kelsey SM, Wu YL, Newland AC.
    Br J Haematol; 1995 Jun 15; 90(2):375-83. PubMed ID: 7794760
    [Abstract] [Full Text] [Related]

  • 13. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F.
    Cancer Res; 1991 Aug 15; 51(16):4226-33. PubMed ID: 1678313
    [Abstract] [Full Text] [Related]

  • 14. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).
    Twentyman PR, Reeve JG, Koch G, Wright KA.
    Br J Cancer; 1990 Jul 15; 62(1):89-95. PubMed ID: 1975203
    [Abstract] [Full Text] [Related]

  • 15. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B, Loor F.
    Anticancer Drugs; 1993 Dec 15; 4(6):605-15. PubMed ID: 7905300
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y, Shimada Y, Shimoyama M.
    Jpn J Cancer Res; 1990 Aug 15; 81(8):834-41. PubMed ID: 2118896
    [Abstract] [Full Text] [Related]

  • 17. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia.
    Keller RP, Altermatt HJ, Nooter K, Poschmann G, Laissue JA, Bollinger P, Hiestand PC.
    Int J Cancer; 1992 Feb 20; 50(4):593-7. PubMed ID: 1347037
    [Abstract] [Full Text] [Related]

  • 18. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR, Burgess R, Fisher A, Yin JA.
    Leuk Res; 1999 Jan 20; 23(1):29-35. PubMed ID: 9933132
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
    Fridborg H, Jonsson B, Nygren P, Csoka K, Nilsson K, Oberg G, Kristensen J, Bergh J, Tholander B, Olsen L.
    Br J Cancer; 1994 Jul 20; 70(1):11-7. PubMed ID: 8018519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.